Associations of early-life pet ownership with asthma and allergic sensitization: A meta-analysis of more than 77,000 children from the EU Child Cohort Network.

Cat FAIR (findable accessible allergic sensitization and reusable) asthma birth cohort children dog exposure interoperable life course epidemiology meta-analysis ownership

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
07 2022
Historique:
received: 01 09 2021
revised: 18 01 2022
accepted: 21 01 2022
pubmed: 13 2 2022
medline: 14 7 2022
entrez: 12 2 2022
Statut: ppublish

Résumé

Studies examining associations of early-life cat and dog ownership with childhood asthma have reported inconsistent results. Several factors could explain these inconsistencies, including type of pet, timing, and degree of exposure. Our aim was to study associations of early-life cat and dog ownership with asthma in school-aged children, including the role of type (cat vs dog), timing (never, prenatal, or early childhood), and degree of ownership (number of pets owned), and the role of allergic sensitization. We used harmonized data from 77,434 mother-child dyads from 9 birth cohorts in the European Union Child Cohort Network when the child was 5 to 11 years old. Associations were examined through the DataSHIELD platform by using adjusted logistic regression models, which were fitted separately for each cohort and combined by using random effects meta-analysis. The prevalence of early-life cat and dog ownership ranged from 12% to 45% and 7% to 47%, respectively, and the prevalence of asthma ranged from 2% to 20%. There was no overall association between either cat or dog ownership and asthma (odds ratio [OR] = 0.97 [95% CI = 0.87-1.09] and 0.92 [95% CI = 0.85-1.01], respectively). Timing and degree of ownership did not strongly influence associations. Cat and dog ownership were also not associated with cat- and dog-specific allergic sensitization (OR = 0.92 [95% CI = 0.75-1.13] and 0.93 [95% CI = 0.57-1.54], respectively). However, cat- and dog-specific allergic sensitization was strongly associated with school-age asthma (OR = 6.69 [95% CI = 4.91-9.10] and 5.98 [95% CI = 3.14-11.36], respectively). There was also some indication of an interaction between ownership and sensitization, suggesting that ownership may exacerbate the risks associated with pet-specific sensitization but offer some protection against asthma in the absence of sensitization. Our findings do not support early-life cat and dog ownership in themselves increasing the risk of school-age asthma, but they do suggest that ownership may potentially exacerbate the risks associated with cat- and dog-specific allergic sensitization.

Sections du résumé

BACKGROUND
Studies examining associations of early-life cat and dog ownership with childhood asthma have reported inconsistent results. Several factors could explain these inconsistencies, including type of pet, timing, and degree of exposure.
OBJECTIVE
Our aim was to study associations of early-life cat and dog ownership with asthma in school-aged children, including the role of type (cat vs dog), timing (never, prenatal, or early childhood), and degree of ownership (number of pets owned), and the role of allergic sensitization.
METHODS
We used harmonized data from 77,434 mother-child dyads from 9 birth cohorts in the European Union Child Cohort Network when the child was 5 to 11 years old. Associations were examined through the DataSHIELD platform by using adjusted logistic regression models, which were fitted separately for each cohort and combined by using random effects meta-analysis.
RESULTS
The prevalence of early-life cat and dog ownership ranged from 12% to 45% and 7% to 47%, respectively, and the prevalence of asthma ranged from 2% to 20%. There was no overall association between either cat or dog ownership and asthma (odds ratio [OR] = 0.97 [95% CI = 0.87-1.09] and 0.92 [95% CI = 0.85-1.01], respectively). Timing and degree of ownership did not strongly influence associations. Cat and dog ownership were also not associated with cat- and dog-specific allergic sensitization (OR = 0.92 [95% CI = 0.75-1.13] and 0.93 [95% CI = 0.57-1.54], respectively). However, cat- and dog-specific allergic sensitization was strongly associated with school-age asthma (OR = 6.69 [95% CI = 4.91-9.10] and 5.98 [95% CI = 3.14-11.36], respectively). There was also some indication of an interaction between ownership and sensitization, suggesting that ownership may exacerbate the risks associated with pet-specific sensitization but offer some protection against asthma in the absence of sensitization.
CONCLUSION
Our findings do not support early-life cat and dog ownership in themselves increasing the risk of school-age asthma, but they do suggest that ownership may potentially exacerbate the risks associated with cat- and dog-specific allergic sensitization.

Identifiants

pubmed: 35150722
pii: S0091-6749(22)00149-X
doi: 10.1016/j.jaci.2022.01.023
pii:
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

82-92

Subventions

Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Angela Pinot de Moira (A)

Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. Electronic address: anpi@sund.ku.dk.

Katrine Strandberg-Larsen (K)

Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Tom Bishop (T)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Marie Pedersen (M)

Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Demetris Avraam (D)

Population Health Sciences Institute, Newcastle University, Newcastle, United Kingdom.

Tim Cadman (T)

Population Health Science, Bristol Medical School, Bristol, United Kingdom; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.

Lucinda Calas (L)

Université de Paris, Centre for Research in Epidemiology and Statistics, INSERM, INRAE, Paris, France.

Maribel Casas (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health, Madrid, Spain.

Blandine de Lauzon Guillain (B)

Université de Paris, Centre for Research in Epidemiology and Statistics, INSERM, INRAE, Paris, France.

Ahmed Elhakeem (A)

Population Health Science, Bristol Medical School, Bristol, United Kingdom; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.

Ana Esplugues (A)

Spanish Consortium for Research on Epidemiology and Public Health, Madrid, Spain; Department of Nursing, University of Valencia, Valencia, Spain; Epidemiology and Environmental Health Joint Research Unit, The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Universitat Jaume I-Universitat de València, Valencia, Spain.

Marisa Estarlich (M)

Spanish Consortium for Research on Epidemiology and Public Health, Madrid, Spain; Department of Nursing, University of Valencia, Valencia, Spain; Epidemiology and Environmental Health Joint Research Unit, The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Universitat Jaume I-Universitat de València, Valencia, Spain.

Rachel E Foong (RE)

Telethon Kids Institute, Perth, Australia; School of Allied Health, Curtin University, Perth, Australia.

Sido Haakma (S)

Genomics Coordination Center, the University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jennifer R Harris (JR)

Center for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Rae-Chi Huang (RC)

Telethon Kids Institute, Perth, Australia.

Hazel Inskip (H)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Aitana Lertxundi (A)

Spanish Consortium for Research on Epidemiology and Public Health, Madrid, Spain; Department of Preventive Medicine and Public Health, University of Basque Country, Leioa, Spain; Biodonostia Health Research Institute, San Sebastian, Spain.

Sara M Mensink-Bout (SM)

Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Johanna L T Nader (JLT)

Department of Genetics and Bioinformatics, Division of Health Data and Digitalisation, Norwegian Institute of Public Health, Oslo, Norway.

Costanza Pizzi (C)

Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Maja Popovic (M)

Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Theodosia Salika (T)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom.

Jordi Sunyer (J)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health, Madrid, Spain; Imim-ParcSalutMar, Spain.

Evelien R Van Meel (ER)

Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Morris A Swertz (MA)

Genomics Coordination Center, the University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Genetics, the University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Vincent W V Jaddoe (VWV)

Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Paul Burton (P)

Population Health Sciences Institute, Newcastle University, Newcastle, United Kingdom.

Liesbeth Duijts (L)

Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Anne-Marie Nybo Andersen (AM)

Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH